Good evening :)
Place Order
Add to Watchlist

Jeevan Scientific Technology Ltd

JSTL

Jeevan Scientific Technology Ltd

JSTL
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹80 cr, stock is ranked 3,152
High RiskStock is 3.01x as volatile as Nifty
52.001.58% (+0.81)
52.001.58% (+0.81)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹80 cr, stock is ranked 3,152
High RiskStock is 3.01x as volatile as Nifty

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹80 cr, stock is ranked 3,152
High RiskStock is 3.01x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
670.811.66
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.096.400.53%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jeevan Scientific Technology Limited is engaged in providing data management services. The Company's segments include Clinical Research Services, Data Management Services and Information Technology Services.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 8.25%, vs industry avg of 4.51%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.22% to 0.23%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue17.7918.7921.3227.1326.4749.3473.7137.2540.3245.86
Raw Materialssubtract0.150.000.000.000.000.003.692.463.8237.75
Power & Fuel Costsubtract0.380.340.470.690.790.800.820.931.06
Employee Costsubtract2.781.895.057.409.2611.0518.1712.6213.28
Selling & Administrative Expensessubtract2.4212.035.653.645.939.5916.269.319.40
Operating & Other expensessubtract9.890.755.808.5514.088.0312.099.517.46
Depreciation/Amortizationsubtract0.681.232.123.133.923.973.695.075.936.04
Interest & Other Itemssubtract1.281.541.872.363.042.260.961.040.981.26
Taxes & Other Itemssubtract0.220.110.250.25-1.961.916.09-0.63-0.310.69
EPS-0.021.170.110.83-5.617.677.80-1.99-0.840.08
DPS0.000.000.000.000.000.501.200.000.000.00
Payout ratio0.000.000.000.000.000.070.150.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CareLabs & Life Sciences Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Jeevan Scientific Technology Ltd-61.921.66
Divi's Laboratories Ltd99.5211.730.50%
Syngene International Ltd68.388.190.14%
Aarti Pharmalabs Ltd27.303.370.46%

Price Comparison

Compare JSTL with any stock or ETF
Compare JSTL with any stock or ETF
JSTL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding38.70%0.00%0.00%0.00%61.30%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 21, 2022

Final
Final | Div/Share: ₹1.20

Dividend/Share

1.20

Ex DateEx Date

Sep 21, 2022

Cash Dividend

Ex DateEx DateSep 7, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 7, 2021

News & Opinions
Earnings
Jeevan Scientific Technology reports consolidated net profit of Rs 0.24 crore in the September 2024 quarter

Net profit of Jeevan Scientific Technology reported to Rs 0.24 crore in the quarter ended September 2024 as against net loss of Rs 0.60 crore during the previous quarter ended September 2023. Sales rose 41.44% to Rs 11.40 crore in the quarter ended September 2024 as against Rs 8.06 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales11.408.06 41 OPM %21.937.44 - PBDT2.210.60 268 PBT0.72-0.83 LP NP0.24-0.60 LP Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Earnings
Jeevan Scientific Technology consolidated net profit rises 109.62% in the June 2024 quarter

Net profit of Jeevan Scientific Technology rose 109.62% to Rs 1.09 crore in the quarter ended June 2024 as against Rs 0.52 crore during the previous quarter ended June 2023. Sales rose 23.97% to Rs 12.88 crore in the quarter ended June 2024 as against Rs 10.39 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8810.39 24 OPM %25.0819.54 - PBDT3.012.10 43 PBT1.490.63 137 NP1.090.52 110 Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Jeevan Scientific Technology standalone net profit rises 175.86% in the June 2024 quarter

Net profit of Jeevan Scientific Technology rose 175.86% to Rs 1.60 crore in the quarter ended June 2024 as against Rs 0.58 crore during the previous quarter ended June 2023. Sales rose 20.50% to Rs 12.52 crore in the quarter ended June 2024 as against Rs 10.39 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.5210.39 21 OPM %27.0819.63 - PBDT3.352.15 56 PBT2.070.73 184 NP1.600.58 176 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Jeevan Scientific Tech. to hold board meeting

Jeevan Scientific Tech. will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live